Viral Vectors for Treating Diseases of the Nervous System by David S. Latchman
Look inside with Google Book Preview
Viral Vectors for Treating Diseases of the Nervous System
By David S. Latchman

Viral Vectors for Treating Diseases of the Nervous System

Edited by See other recent books by David S. Latchman
Format: Hardback

Normal Price: $238.95
Your Price: $215.06 AUD, inc. GST
Shipping: $7.95 per order
You Save: $23.89! (10% off normal price)
Plus...earn $10.75 in Boomerang Bucks
Availability: Available Available to Backorder, No Due Date for Supply, Not for Xmas

Viral Vectors for Treating Diseases of the Nervous System by David S. Latchman

Book Description

Gene therapy offers considerable potential for the treatment of various incurable diseases of the nervous system. This volume describes a number of different viral vectors developed for achieving high efficiency gene delivery to the brain. Vectors described include those based on adenovirus, adeno-associated virus, Herpes Simplex Virus, lentivirus, and other retroviruses. It also discusses the potential application of such viruses in treating brain tumors, Parkinson's disease, and other diseases of the nervous system. It provides up-to-date account of gene therapy approaches for incurable neurological disorders and describes a range of gene delivery methods based on different viruses.

Buy Viral Vectors for Treating Diseases of the Nervous System book by David S. Latchman from Australia's Online Bookstore, Boomerang Books.

Book Details

ISBN: 9780123668561
ISBN-10: 0123668565
Format: Hardback
(229mm x 152mm x 20mm)
Pages: 329
Imprint: Academic Press Inc
Publisher: Elsevier Science Publishing Co Inc
Publish Date: 7-Oct-2003
Country of Publication: United States

Books By Author David S. Latchman

Eukaryotic Transcription Factors by David S. Latchman Eukaryotic Transcription Factors, Paperback (September 2007)

Provides coverage of the developments, from enabling genomic technologies to studies on the importance of post-translational modifications beyond phosphorylation events. This book also covers: the potential of transcription factors as therapeutic targets in human disease; importance of histone modifications; and transcriptional elongation.

Transcription Factors by David S. Latchman Transcription Factors, Paperback (April 1999)

Transcription factors are proteins that interact with specific DNA sequences to enable transcription to occur. The popular first edition was published five years ago and all chapters have been extensively revised and four new chapters added to give a comprehensive guide to all the methods required to analyse transcription factors.

Basic Molecular and Cell Biology by David S. Latchman Basic Molecular and Cell Biology, Paperback (September 1997)

This third, fully revised edition, brings the reader up to date with recent advances made in the study of disease at the molecular and cellular level, and examines the new possibilities for treatment. Subjects covered include methods used in molecular medicine and the polymerase chain reaction.

» View all books by David S. Latchman


» Have you read this book? We'd like to know what you think about it - write a review about Viral Vectors for Treating Diseases of the Nervous System book by David S. Latchman and you'll earn 50c in Boomerang Bucks loyalty dollars (you must be a member - it's free to sign up!)

Write a book review

Author Biography - David S. Latchman

David S. Latchman graduated with a BA (First Class Honours) in Natural Sciences from Cambridge University and subsequently obtained a PhD in Genetics from Cambridge University. Following a period of post-doctoral research at Imperial College London, he was appointed to a lectureship at University College London in 1984. Subsequent appointments at UCL included Director of the Medical Molecular Biology Unit (1988), Professor of Molecular Pathology and Head of the Department of Molecular Pathology (1991), Director of the Windeyer Institute of Medical Sciences (1996) and in 1999, Dean of the Institute of Child Health and Professor of Human Genetics. At the beginning of 2003, he took up a new appointment as Master of Birkbeck, University of London, leading this multi-faculty College comprising over 1,000 staff and 16,000 students studying at levels from short courses to PhDs. He continues to retain an active research laboratory at the Institute of Child Health, UCL and in recognition of this he is now Professor of Genetics at Birkbeck and UCL. Since he set up his own laboratory in 1984, Professor Latchmans interests have focused particularly on the regulation of gene expression in mammalian cells by specific transcription factors. Initial studies, involved the eukaryotic virus Herpes Simplex Virus (HSV) and were aimed at elucidating why this virus was able to replicate in epithelial cells, whilst establishing silent latent infections in neuronal cells. The identification of a cellular POU family transcription factor, Oct-2, which was expressed in neuronal cells and blocked the virus-lytic cycle, led to an interest in the role of specific POU family transcription factors in regulating cellular as well as viral gene expression in neuronal cells. As well as studies of the role of Oct-2, these investigations resulted in the characterisation of a small sub-family of POU family transcription factors which comprised three members: Brn-3a, Brn-3b and Brn-3c. In particular, the key role of Brn-3a in promoting neuronal differentiation and enhancing the survival of neuronal cells was defined by Professor Latchmans laboratory and has important therapeutic potential for the treatment of human neurodegenerative diseases involving losses of neuronal cells. More recently, Professor Latchmans group has also studied the role of specific transcription factors in the heart and in particular, in its response to damage caused by ischaemia, as in a heart attack. They have demonstrated that a specific transcription factor STAT-1 becomes activated during ischaemia and induces a number of genes which enhance the programmed cell death of cardiac cells, resulting in the loss of these irreplaceable cells. Thus, inhibition of STAT-1 represents a potential therapeutic mechanism for decreasing the damage caused by interruption of blood flow to the heart. On the basis of his scientific research, Professor Latchman was awarded a DSc by London University in 1994 and was appointed a Fellow of the Royal College of Pathologists (FRCPath) in 1999. He serves on a number of Committees, including the Department of Health, Genetics and Insurance Committee, the National Biological Standards Board and its Scientific Policy Advisory Committee, the Health Protection Agency and the Research Strategy Committee of the Higher Education Funding Council for England.

Boomerang Bucks close

For every $20 you spend on books, you will receive $1 in Boomerang Bucks loyalty dollars. You can use your Boomerang Bucks as a credit towards a future purchase from Boomerang Books. Note that you must be a Member (free to sign up) and that conditions do apply.

Recent books by David S. Latchman close
Gene Control by David S. Latchman
Eukaryotic Transcription Factors by David S. Latchman
Transcription Factors by David S. Latchman
Basic Molecular and Cell Biology by David S. Latchman
» close